Happy holidays! To the clients that challenged us. To the partners that supported us. To the colleagues that delivered all year long. Thank you for making 2021 such an interesting, exciting and fulfilling year! Together, we drive the future of medicine.
This year, we are particularly proud to have launched our very own biotech valuation courses and published a book on the topic. We are glad to fill a knowledge gap in valuations of biotech companies in the Nordics by offering these courses (and book). It is a unique environment and this helps to prepare in the competitive market of M&As and licensing agreements. The next session will be held in January, a perfect start to the new year by up-skilling yourself or the team!
In 2021, we have also been fortunate to welcome several new colleagues to the team. We have grown our client list with both new and returning clients across several therapeutic areas. A receipt of work well done if we have ever seen one.
Our hope for 2022 is to be spending more time with our clients and colleagues, preferably in person if deemed safe. But before that, we will enjoy the holidays with our loved ones and hope you will too.
We wish you all a Merry Christmas and a Happy New Year.
Sincerely,
The MSC team
P.S. In lieu of client gifts this season, we have chosen to make a donation to Barncancerfonden supporting their important quest to eradicate childhood cancer.
